Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8951223 | Journal of Vascular Surgery | 2018 | 13 Pages |
Abstract
Reinterventions after F/B-EVAR were necessary in 26% of patients, most commonly for type III endoleaks and target artery complications. Whereas all but one reintervention was successful, many of these required complex procedures with significant morbidity and mortality. Development of strategies to eliminate type III endoleaks by improving component junction integrity and to ensure target artery primary patency are key next steps in the evolution of F/B-EVAR.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Shernaz S. MS, MBA, Jessica P. MD, MPH, Kyle R. MD, Julie M. MS, Francesco A. MD, Edward J. MD, Louis M. MD, Andres MD,